Target intelligence / Profile preview

Calcium metabolism pathway

Molecular classification
Other (biological pathway)
01

Overview

The **calcium metabolism pathway** refers to a complex physiological network that regulates the movement and balance of calcium ions in and out of body compartments—including absorption from the gut (regulated by active vitamin D), storage/release from bone (regulated by parathyroid hormone [PTH] and calcitonin), renal reabsorption/excretion in kidneys—and their distribution between blood plasma and tissues. This process is essential for maintaining plasma calcium homeostasis within narrow limits. Key molecular players include hormones like PTH and calcitonin; transporters such as TRPV6/5 channels for intestinal absorption; calbindin proteins; Na+/Ca2+ exchangers; Ca2+-ATPases for cellular export/import; intracellular stores regulated by IP3R/RYR receptors in endoplasmic reticulum/muscle cells; mitochondrial uniporters for energy coupling. Dysregulation leads to various clinical conditions including osteoporosis, hypocalcemia/hypercalcemia syndromes, chronic kidney disease-related mineral disorders. The “calcium metabolism pathway” is not itself a druggable molecular target but encompasses many individual targets that can be modulated therapeutically. **Note:** "Calcium metabolism pathway" is not a canonical molecule/receptor but describes an integrated biological process involving multiple molecules. It should not be considered a therapeutic target per se—rather it comprises several valid drug targets within its network.

Other names
Calcium homeostasisCalcium signaling pathwayCalcium regulatory pathwayCalcium metabolic pathway
02

Mechanism of action

Drugs target specific proteins or receptors within the calcium metabolism pathway—such as parathyroid hormone receptor agonists/antagonists or vitamin D receptor modulators—but not the entire pathway as a single entity

03

Biological functions

Regulation of mineral metabolismSignal transductionBone remodelingHormonal regulation (via PTH, calcitonin, vitamin D)Cellular energy metabolismCell cycle regulation
04

Disease associations

Osteoporosis and bone diseasesHypercalcemia/hypocalcemia disordersChronic kidney disease-mineral and bone disorder (CKD-MBD)Endocrine disorders (e.g., parathyroid dysfunction)Dermatological diseases
05

Safety considerations

Safety concerns relate to interventions targeting individual components such as risk of hypercalcemia with excessive supplementation or therapy
06

Biomarkers

serum calcium levelsPTH levels25(OH)D/vitamin D status

Beyond the preview

Go deeper on Calcium metabolism pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium metabolism pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call